CTRI/2024/04/065433尚未招募3 期
An Interventional Prospective Clinical Study To Assess The Role Of Indicated Homoeopathic Medicines In The Management Of Gout - nil
Dr M P K Homoeopathic Medical College Hospital and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •As per the following list of clinical features shown by the patient If four symptoms should be found out of eight symptoms the cases shall be enrolled for the study
- •1 Serum urate level more than 6mg/dl in women and more than 7mg/dl in men
- •2 More than one attack of acute arthritis maximum inflammation developed in one day
- •3 Redness observed in joints
- •4 Unilateral first MTP joint painful or swollen
- •5 Unilateral tarsal joint attack
- •6 Asymmetrical swelling within a joint
- •7 Tophus or Subcortical cysts without erosion on x ray
- •8 History of complete termination of an attack after treatment
- •Pre diagnosed cases of gout patients who are seeking for homoeopathic treatment
排除标准
- •1 Pregnant women and lactating women are not included
- •2 Patient who need emergency treatment
- •3 Patient with severe systemic illness
- •4 Patients who are not willing to give written consent for the study
研究者
相似试验
已完成
不适用
A Clinical Study to evaluate the effectiveness of Jolly Tulsi 51 drops for Boosting Immune system and Detoxification in healthy subjects.CTRI/2018/02/012126Jolly Health Care30
招募中
Unknown
Prospective interventional clinical study to evaluate the efficacy and safety of atezolizumab plus bevacizumab in combination with carbon ion radiotherapy for unresectable hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000051549Yamagata University20
已完成
3 期
Effectiveness of Homoeopathic medicines in Hypertrophied AdenoidCTRI/2019/11/022163DR SHAREENA C P30
招募中
1 期
REIMAGINE – Real-world EvaluatIon of Mepolizumab in severe Asthma achievinG on treatment clinIcal remissioN, a prospEctive study.severe asthmaMedDRA version: 21.1Level: LLTClassification code: 10068462Term: Eosinophilic asthma Class: 10038738CTIS2023-509026-21-00Glaxosmithkline Research & Development Limited336
尚未招募
2 期
A clinical trial to assess efficacy of Angiotensin Receptor Nephrilysin Inhibitor (Sacubitril/Valsartan) in right ventricular systolic dysfunction with normal LV functionâ??CTRI/2023/01/049280MDM hospitalDr SN Medical College